Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Electronic Theses and Dissertations bannerUCLA

Endoscopic Trans-Oral Outlet reduction in Combination with Gastroplasty (TORe-G) is a Novel Technique that is Highly Efficacious and Safe for Weight Loss in Patients with Failed Roux-en-Y Gastric Bypass (RYGB)

Abstract

Introduction: Enlargement of the remnant gastric pouch and gastro-jejunal (GJ) stoma are associated with weight regain after RYGB surgery. Current evidence suggests an excess weight loss (%EWL) of 12-25% with GJ outlet reduction (TORe) alone. However, the efficacy of a combined approach using endoscopic trans-oral outlet reduction (TORe) in combination with Gastroplasty of the entire gastric pouch from the gastro-esophageal (GE) junction to the GJ stoma (TORe-G) is unknown.

Methods: Patients who experienced inadequate weight loss (<50% EWL) or weight regain (>25% EWL from nadir) post-RYGB along with evidence of dilated GJ stoma and gastric pouch underwent a combined GJ stoma reduction and gastroplasty. The procedure involved ablation of the peristomal mucosa and gastric pouch using APC and placement of interrupted and running full-thickness plications (Overstitch, Apollo Endosurgery, Austin Tx) for a targeted GJ diameter of ~5-8 mm and significant reduction of gastric pouch volume.

Results: 40 patients (78% females) with age 53?10 years, BMI 41?9 kg/m2, and time since RYGB 10?4 years were prospectively studied. Significant weight loss (>5% TBWL) was seen in 90% patients. Post Tore-G, mean (95% CI) %TBWL observed at 1, 3, 6, 9 and 12 months follow up was 7.6 (5-10.1), 10.4 (8.1-12.8), 12.3 (9.6-14.9), 13.3 (10.4-16.2), and 14.1 (10.9-17.2) respectively. Corresponding %EWL was 24.1 (15.9-32.3), 31.3 (23.7-38.9), 35.9 27.3-44.4), 38.5 (29.1-47.9), and 40.4 (30.2-50.6); and %RWL was 39.6 (22.1-57), 52.1 (35.5 -68.8), 60.1 (41.9-78.3), 64.7 (45-84.5), and 68 (47-89) respectively. No covariates including age, sex, interval time since RYGB, % weight regained were significantly associated with weight loss over time. No serious adverse events were observed.

Conclusions: We demonstrate for the first time the efficacy and safety of TORe-G to re-establish weight loss in patients with failed RYGB using a full thickness endoscopic suturing device. TORe-G resulted in robust weight loss and superior outcomes compared with published data with TORe alone.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View